Reneo Pharmaceuticals, Inc. Stock Forecast
Reneo Pharmaceuticals, Inc. stock upgraded to Buy Candidate.
(Updated on May 03, 2024)
The Reneo Pharmaceuticals, Inc. stock price gained 0.578% on the last trading day (Friday, 3rd May 2024), rising from $1.73 to $1.74. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 2.91% from a day low at $1.72 to a day high of $1.77. The price has risen in 5 of the last 10 days. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 71 thousand more shares were traded than the day before. In total, 110 thousand shares were bought and sold for approximately $191.28 thousand.
The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 4.15% during the next 3 months and, with a 90% probability hold a price between $1.71 and $1.88 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
RPHM Signals & Forecast
The Reneo Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.69 and $1.69. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 5.45%. Further rise is indicated until a new top pivot has been found. Reneo Pharmaceuticals, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Reneo Pharmaceuticals, Inc. stock
Reneo Pharmaceuticals, Inc. finds support from accumulated volume at $1.66 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.0500 (2.91%) between high and low. For the last week, the stock has had daily average volatility of 3.20%.
Our recommended stop-loss: $1.67 (-4.25%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 6 days ago.)
Trading Expectations (RPHM) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect Reneo Pharmaceuticals, Inc. to open at $1.74, and during the day (based on 14 day Average True Range), to move between $1.67 and $1.81, which gives a possible trading interval of +/-$0.0662 (+/-3.80%) up or down from last closing price. If Reneo Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 7.60% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.76 (1.15%) than the support at $1.66 (4.60%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
Reneo Pharmaceuticals, Inc. will release earnings -- on Thursday, May 09, 2024. We will update the financials statements for Reneo Pharmaceuticals, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 11.09% in the first trading day after earnings release.
Is Reneo Pharmaceuticals, Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Reneo Pharmaceuticals, Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.
Current score: 2.399 Buy Candidate Upgraded
Predicted Opening Price for Reneo Pharmaceuticals, Inc. of Monday, May 6, 2024
Fair opening price May 6, 2024 | Current price |
---|---|
$1.74 ( 0.192%) | $1.74 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for RPHM
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 1.79 | 3.07 % | |
R2 | 1.77 | 1.97 % | ||
R1 | 1.76 | 1.29 % | ||
Current price: | 1.74 | |||
Support | S1 | 1.72 | -0.91 % | |
S2 | 1.71 | -1.58 % | ||
S3 | 1.69 | -2.68 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0 | . | |
R2 | 1.77 | 1.72 % | ||
R1 | 1.76 | 1.15 % | ||
Current price | 1.74 | |||
Support | S1 | 1.66 | -4.60% | |
S2 | 1.65 | -5.17% | ||
S3 | 1.64 | -5.75% |
FAQ
Click here for our free guide on how to buy Reneo Pharmaceuticals, Inc. Stock.